Sands Capital Management
AGN

Sands Capital Management’s Allergan plc AGN Stock Holding History

Sands Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-45,058
Closed -$7.58M – 67
2018
Q1 		$7.58M Buy
45,058
+14,985
+50% +$2.51M 0.02% 59
2017
Q4 		$4.92M Buy
30,073
+24,455
+435% +$4.39M 0.01% 62
2017
Q3 		$1.15M Buy
5,618
+190
+4% +$44.2K ﹤0.01% 60
2017
Q2 		$1.32M Sell
5,428
-125
-2% -$29.4K ﹤0.01% 57
2017
Q1 		$1.33M Buy
+5,553
New +$1.29M ﹤0.01% 54

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Sands Capital Management's AGN Position: Q2 2018 in Review

Sands Capital Management sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 45,058 shares — an estimated $7.58M sold.

Sands Capital Management first reported a position in AGN in Q1 2017 and held it in 5 quarters. The position peaked at $7.58M in Q1 2018. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Sands Capital Management reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Sands Capital Management sold 45,058 Allergan plc shares in Q2 2018, an estimated $7.58M.
  • Sands Capital Management first reported a position in Allergan plc in Q1 2017 and held it in 5 quarters.
  • Sands Capital Management's Allergan plc position peaked at $7.58M in Q1 2018.
  • 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Sands Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.